Drugs for Liver Cancer (Hepatocellular Carcinoma)

Table. Drugs Prescribed for Liver Cancer (Hepatocellular Carcinoma)

• Drug name (generic name)
• Drug company
• Indications
• Patient support services

Drug name (generic name)
• Cabometyx (cabozantinib) Tablets
Drug company
• Exelixis
Indications
• Treatment of patients with liver cancer (hepatocellular carcinoma), after Nexavar
Patient support services
• EASE Co-pay Program
  844-900-3273
  
  EASE Patient Assistance Program
  844-900-3273

Drug name (generic name)
• Cyramza (ramucirumab) Injection
Drug company
• Eli Lilly
Indication
• Treatment as a single therapy of liver cancer in patients with alpha fetoprotein of 400 ng/mL or more, after Nexavar
Patient support services
• Lilly Oncology Infused Products Co-pay Program
  866-472-8663
  
  Lilly Cares Foundation Patient Assistance Program
  800-545-6962

Drug name (generic name)
• Defitelio (defibrotide sodium)
Drug company
• Jazz Pharmaceuticals
Indication
• Treatment of hepatic veno-occlusive disease (often associated with cancer-related transplant)
Patient support services
• JazzCares Patient Assistance Program
  833-533-5299

Drug name (generic name)
• Imjudo (tremelimumabactl) Injection
Drug company
• AstraZeneca
Indication
• Treatment of adults, in combination with durvalumab, for unresectable liver cancer
Patient support services
• IMJUDO Co-pay Savings Program
  844-257-2360
  
  AZ&Me Prescription Savings Program
  800-292-6363

Drug name (generic name)
• Keytruda (pembrolizumab)
Drug company
• Merck
Indication
• Treatment of patients with liver cancer who have previously received Nexavar
Patient support services
• Merck Co-pay Assistance Program
  855-257-3932
  
  Merck Patient Assistance Program
  855-257-3932

Drug name (generic name)
• Lenvima (lenvatinib) Capsules
Drug company
• Eisai
Indication
• First-line treatment of patients with unresectable liver cancer
Patient support services
• Lenvima $0 Co-pay Program
  866-613-4724
  
  Lenvima Patient Assistance Program
  866-613-4724

Drug name (generic name)
• Nexavar (sorafenib) Tablets
Drug company
• Bayer
Indication
• Treatment of patients with unresectable liver cancer
Patient support services
• NEXAVAR $0 Co‑Pay Program
  866-581-4992
  
  Bayer US Patient Assistance Foundation
  866-228-7723

Drug name (generic name)
• Opdivo (nivolumab)
Drug company
• Bristol Myers Squibb
Indication
• Treatment, alone or in combination with Yervoy, of patients with liver cancer who have previously received Nexavar
Patient support services
• BMS Oncology Co‑Pay Assistance Program
  800-861-0048
  
  Bristol Myers Squibb Patient Assistance Foundation
  800-736-0003

Drug name (generic name)
• Stivarga (regorafenib) Tablets
Drug company
• Bayer
Indication
• Treatment of patients with liver cancer, after treatment with Nexavar
Patient support services
• STIVARGA $0 Co‑Pay Program
  866-581-4992
  
  Bayer US Patient Assistance Foundation
  866-228-7723

Drug name (generic name)
• Tecentriq (atezolizumab)
Drug company
• Genentech
Indication
• Treatment, in combination with Avastin, of patients with unresectable or metastatic liver cancer who have not received systemic therapy
Patient support services
• Genentech Oncology Co‑pay Assistance Program
  866-422-2377
  
  Genentech Patient Foundation
  866-422-2377

Drug name (generic name)
• Yervoy (ipilimumab)
Drug company
• Bristol Myers Squibb
Indication
• Treatment, in combination with Opdivo, of patients with liver cancer after treatment with Nexavar
Patient support services
• BMS Oncology Co‑Pay Assistance Program
  800-861-0048
  
  Bristol Myers Squibb Patient Assistance Foundation
  800-736-0003